Ambelvist Injection
Product Images NDC 50419-321

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Ambelvist (NDC 50419-321). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bayer Healthcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Gadoquatrane 01)

Chemical Structure (Gadoquatrane 01)
Chemical structure of gadoquatrane, the active ingredient in Ambelvist injection 257.9 mg/mL by Bayer HealthCare Pharmaceuticals Inc. The diagram shows the molecular arrangement of atoms and bonds including gadolinium (Gd) complexed structures prominent in the molecule.*
FDA Label Image

Principal Display Panel (2 mL Vial Carton)

Principal Display Panel (2 mL Vial Carton)
Ambelvist (gadoquatrane) injection 0.2 mmol/2 mL (0.1 mmol/mL) packaging label for intravenous administration. The label indicates single-dose vials, a 3 x 2 mL sterile solution package, and Rx only. It is manufactured by Bayer HealthCare Pharmaceuticals Inc. The label includes dosing details and storage instructions along with the Bayer logo.*
FDA Label Image

Principal Display Panel (7.5 mL Vial Carton)

Principal Display Panel (7.5 mL Vial Carton)
Packaging label for Ambelvist (gadoquatrane) injection, 0.75 mmol/7.5 mL (0.1 mmol/mL) sterile solution. This prescription drug by Bayer HealthCare Pharmaceuticals Inc. is for intravenous administration and comes in single-dose vials. The package contains 10 vials of 7.5 mL each. The label includes dosing and handling instructions along with the NDC 50419-322-11.*
FDA Label Image

Principal Display Panel (10 mL Vial Carton)

Principal Display Panel (10 mL Vial Carton)
The packaging label for Ambelvist (gadoquatrane) injection, 1 mmol/10 mL (0.1 mmol/mL), displays it as an intravenous, sterile solution supplied in 10 x 10 mL single-dose vials. The label indicates it is Rx only and instructs to discard unused portions. Bayer HealthCare Pharmaceuticals Inc. is the labeler.*
FDA Label Image

Principal Display Panel (15 mL Vial Carton)

Principal Display Panel (15 mL Vial Carton)
Ambelvist (gadoquatrane) injection 1.5 mmol/15 mL (0.1 mmol/mL) intravenous sterile solution by Bayer HealthCare Pharmaceuticals Inc. The packaging is for 10 vials of 15 mL each, labeled for prescription use only. The label includes usage instructions to discard unused portions and to dispense the enclosed Medication Guide to each patient.*
FDA Label Image

Principal Display Panel (30 mL Vial Carton)

Principal Display Panel (30 mL Vial Carton)
Ambelvist (gadoquatrane) injection 3 mmol/30 mL (0.1 mmol/mL) sterile solution label for an imaging bulk package by Bayer HealthCare Pharmaceuticals Inc. The label indicates a 10 x 30 mL package size, for intravenous use only, Rx only. The label includes warnings about discard timing and packaging instructions, stating it is not for direct infusion.*
FDA Label Image

Principal Display Panel (65 mL Bottle Label)

Principal Display Panel (65 mL Bottle Label)
Ambelvist (gadoquatrane) injection 6.5 mmol/65 mL (0.1 mmol/mL) is an intravenous sterile solution supplied in a 10 x 65 mL imaging bulk package by Bayer HealthCare Pharmaceuticals Inc. The label includes usage instructions, storage conditions, and states it is for prescription use only.*
FDA Label Image

Principal Display Panel (30 mL Bottle Carton)

Principal Display Panel (30 mL Bottle Carton)
Ambelvist (gadoquatrane) injection 3 mmol/30 mL (0.1 mmol/mL) sterile solution for intravenous use. Packaging indicates a pharmacy bulk package containing 10 x 30 mL units, labeled Rx only. The product is manufactured by Bayer HealthCare Pharmaceuticals Inc. and includes instructions to discard 6 hours after initial puncture and to dispense the enclosed medication guide to each patient.*
FDA Label Image

Principal Display Panel (65 mL Bottle Label)

Principal Display Panel (65 mL Bottle Label)
Ambelvist (gadoquatrane) injection 6.5 mmol/65 mL (0.1 mmol/mL) sterile solution for intravenous use. Pharmacy bulk package labeled not for direct infusion, with a quantity of 10 x 65 mL. Manufactured for Bayer HealthCare Pharmaceuticals Inc. The label includes storage instructions and ingredient details for each mL.*
FDA Label Image

Principal Display Panel (7.5 mL Syringe Carton)

Principal Display Panel (7.5 mL Syringe Carton)
Ambelvist (gadoquatrane) injection 0.75 mmol/7.5 mL (0.1 mmol/mL) packaging label for Bayer HealthCare Pharmaceuticals Inc. This carton contains 5 pre-filled disposable syringes of 7.5 mL each for intravenous administration. The sterile solution is Rx only, with emphasis on sterility and disposal instructions. The label includes the NDC 50419-330-11 and features the Bayer logo.*
FDA Label Image

Principal Display Panel (10 mL Syringe Carton)

Principal Display Panel (10 mL Syringe Carton)
Carton packaging label for Ambelvist (gadoquatrane) injection, 1 mmol/10 mL (0.1 mmol/mL), containing 5 pre-filled 10 mL syringes. The label indicates it is a sterile solution for intravenous administration, single-dose syringes, and notes the product is by Bayer HealthCare Pharmaceuticals Inc. The label includes the NDC 50419-331-11.*
FDA Label Image

Principal Display Panel (15 mL Syringe Carton)

Principal Display Panel (15 mL Syringe Carton)
Ambelvist (gadoquatrane) injection 1.5 mmol/15 mL (0.1 mmol/mL) in a carton for pre-filled disposable 15 mL syringes. The label indicates 5 x 15 mL pre-filled syringes, Rx only, sterile solution, for intravenous administration. Manufactured by Bayer HealthCare Pharmaceuticals Inc. The packaging includes usage instructions and cautions about sterility.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.